USE OF A PKC-DELTA INHIBITOR FOR THE INHIBITION OF METASTATIC MELANOMA Read more about USE OF A PKC-DELTA INHIBITOR FOR THE INHIBITION OF METASTATIC MELANOMA Patent Cooperation TreatyPCT/US2004/041610Filed on 2004-12-13
Anti-CD30 Stalk and anti-CD-30 Antibodies Suitable For Use in Immunotoxins Read more about Anti-CD30 Stalk and anti-CD-30 Antibodies Suitable For Use in Immunotoxins US Patent 7,470,775Filed on 2004-12-03
SUBSTITUTED O6-BENZYLGUANINES AND 7-OR 9-SUBSTITUTED 8-AZA-O6-BENZYLGUANINES Read more about SUBSTITUTED O6-BENZYLGUANINES AND 7-OR 9-SUBSTITUTED 8-AZA-O6-BENZYLGUANINES European Patent04030121.0Filed on 1995-07-31
CHONDROPSIN-CLASS ANTITUMOR V-ATPASE INHIBITOR COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF Read more about CHONDROPSIN-CLASS ANTITUMOR V-ATPASE INHIBITOR COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF Canada2493821Filed on 2003-07-24
CHONDROPSIN-CLASS ANTITUMOR V-ATPASE INHIBITOR COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF Read more about CHONDROPSIN-CLASS ANTITUMOR V-ATPASE INHIBITOR COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF Australia2003269924Filed on 2003-07-24
CHONDROPSIN-CLASS ANTITUMOR V-ATPASE INHIBITOR COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF Read more about CHONDROPSIN-CLASS ANTITUMOR V-ATPASE INHIBITOR COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF European Patent03751813.1Filed on 2003-07-24
CHONDROPSIN-CLASS ANTITUMOR V-ATPASE INHIBITOR COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF Read more about CHONDROPSIN-CLASS ANTITUMOR V-ATPASE INHIBITOR COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF US Patent 7,205,334Filed on 2005-04-18
PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES Read more about PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES Ireland01948294.2Filed on 2001-06-08
PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES Read more about PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES Denmark01948294.2Filed on 2001-06-08
PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES Read more about PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES Austria01948294.2Filed on 2001-06-08